|
CAMSAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.48380205292165E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.49210000413669E-08 |
| Normal-vs-Stage2 |
6.098300E-03 |
| Normal-vs-Stage3 |
4.084200E-02 |
| Normal-vs-Stage4 |
4.764800E-01 |
| Stage1-vs-Stage2 |
6.426600E-01 |
| Stage1-vs-Stage3 |
8.490000E-01 |
| Stage1-vs-Stage4 |
5.380900E-03 |
| Stage2-vs-Stage3 |
8.510000E-01 |
| Stage2-vs-Stage4 |
9.945600E-02 |
| Stage3-vs-Stage4 |
1.181640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.35620009351123E-10 |
| Normal-vs-AfricanAmerican |
1.84343999999337E-05 |
| Normal-vs-Asian |
7.755600E-01 |
| Caucasian-vs-AfricanAmerican |
5.593200E-01 |
| Caucasian-vs-Asian |
9.158000E-03 |
| AfricanAmerican-vs-Asian |
8.393800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.75479972167147E-10 |
| Normal-vs-Female |
4.66619999994755E-06 |
| Male-vs-Female |
8.069200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.717600E-03 |
| Normal-vs-Extreme_Weight |
5.69769999999581E-05 |
| Normal-vs-Obese |
4.78760000000023E-06 |
| Normal-vs-Extreme_Obese |
1.524560E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.624000E-01 |
| Normal_Weight-vs-Obese |
5.391900E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.947400E-01 |
| Extreme_Weight-vs-Obese |
1.543600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.952000E-01 |
| Obese-vs-Extreme_Obese |
2.712000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.680380E-02 |
| Normal-vs-Age(41-60Yrs) |
6.25489993133499E-10 |
| Normal-vs-Age(61-80Yrs) |
1.02020000003478E-06 |
| Normal-vs-Age(81-100Yrs) |
2.864800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.298400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.811400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.486200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.384900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.103390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.090600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.97708516225248E-12 |
| Normal-VS-Type2 PRCC |
2.764200E-02 |
| Normal-VS-KIRP CIMP |
1.768280E-02 |
| Normal-VS-Unclassified PRCC |
1.464750E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.05019999994272E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.023800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.672200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.249380E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.154000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.833600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.870350E-02 |
| Normal-vs-N1 |
9.004300E-03 |
| Normal-vs-N2 |
1.683810E-01 |
| N0-vs-N1 |
3.112200E-01 |
| N0-vs-N2 |
9.568800E-01 |
| N1-vs-N2 |
6.097800E-01 |
|
|
